What Youll Learn Learn how GLP-1s affect body, behavior, and mindset, and gain tools to coach clients through every stage of their journey
Rough estimates based on the number needed to treat suggest tirzepatide is superior to resmetirom in both MASH regression and fibrosis improvement (1.9 vs
Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J, Okechukwu K
Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated that almost 50 million adults in employer plans meet the clinical criteria for taking such drugs, which can cost thousands of dollars annually per person
doi:10.1016/j.cell.2016.05.023 (5) Yang D, et al
Background Type 2 diabetes mellitus (T2DM) is a chronic condition that affects millions of patients worldwide, posing significant challenges to both patients and healthcare systems